2023-08-08 14:15:00
Julian Read, CEO for Simris Group AB clarifies the strategic focus for the Company, its business model for its Antibody Drug Conjugate (ADC) products and how funds from the ongoing capital raising will be prioritised during an interview with Finwire.
The interview can be viewed at www.youtube.com/watch?v=ogonDAE4UuY&t=12s.